Will public trust in science survive the pandemic? (Unknown)
In:
Chemical & Engineering News
;
99
, 3
;
19-29
;
2021
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Will public trust in science survive the pandemic?
-
Additional title:C&EN
-
Published in:Chemical & Engineering News ; 99, 3 ; 19-29
-
Publisher:
- New search for: American Chemical Society
-
Place of publication:Washington, DC
-
Publication date:2021-01-25
-
ISSN:
-
Coden:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 99, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Table of Contents| 2021
- 2
-
Science’s greatest test| 2021
- 3
-
Biden chooses science advisers| 2021
- 4
-
Ants fight fungi with compound from bacteria| 2021
- 4
-
Catalyst boosts prospects for fuel-cell vehicles| 2021
- 5
-
ID’ing structure and function of copper’s active sites| 2021
- 5
-
Surface swabbing could predict COVID-19 cases| 2021
- 6
-
Method writes digital data directly in cells| 2021
- 6
-
Kombucha inspires smart, living film| 2021
- 7
-
Catalyst works differently depending on how it’s activated| 2021
- 8
-
Copulating cancer cells| 2021
- 8
-
Podcast: Historians decode centuries-old chemical secrets| 2021
- 8
-
Beryllium doubles down on nitrogen bonding| 2021
- 9
-
Chemical, drug firms respond to electoral riot at the US Capitol| 2021
- 9
-
Lilly reports good results in small Alzheimer’s trial| 2021
- 10
-
Green H2 projects ramp up in Europe| 2021
- 10
-
Grace will consider takeover offer| 2021
- 11
-
Albemarle to double US lithium output| 2021
- 12
-
Sanofi picks name, CEO for its API spin-off| 2021
- 12
-
Ashland will buy a personal care business| 2021
- 12
-
Ineos funds antimicrobial R&D| 2021
- 12
-
Thermo Fisher acquires Novasep’s viral vector unit| 2021
- 12
-
Lanxess to buy 2 disinfectant makers| 2021
- 12
-
Arkema venture to make new glue| 2021
- 12
-
BASF surprises with strong earnings| 2021
- 13
-
Dana-Farber forms its own venture fundBoston’s| 2021
- 13
-
Lilly to license Merus antibody therapy| 2021
- 13
-
Contractors plan US biologic drug facilities| 2021
- 13
-
Atalanta launches for branched RNAi therapy| 2021
- 13
-
NextPharma will buy 2 Lonza plants| 2021
- 13
-
Business Roundup| 2021
- 14
-
Violet dye presents health risks to workers| 2021
- 14
-
Trump EPA hands citrus growers a parting gift| 2021
- 15
-
Mosquito spray tainted with PFAS from containers| 2021
- 15
-
As term ends, Trump EPA acts on PFAS| 2021
- 16
-
COVID-19: Science’s greatest test| 2021
- 19
-
Will public trust in science survive the pandemic?| 2021
- 30
-
How COVID-19 has changed the culture of science| 2021
- 34
-
Ads| 2021
- 34
-
Classifieds| 2021
- 34
-
Masthead| 2021
- 38
-
8 tools that helped us tackle the coronavirus| 2021
- 44
-
Is drug repurposing worth the effort?| 2021
- 48
-
An intense race| 2021
- 50
-
In memoriam| 2021
- 56
-
Soothsaying science and salt gets saltier| 2021